The History of Live Attenuated <i>Centrin</i> Gene-Deleted <i>Leishmania</i> Vaccine Candidates

The History of Live Attenuated <i>Centrin</i> Gene-Deleted <i>Leishmania</i> Vaccine Candidates

Leishmaniasis, caused by an infection of the <i>Leishmania</i> protozoa, is a neglected tropical disease and a major health problem in tropical and subtropical regions of the world, with approximately 350 million people worldwide at risk and 2 million new cases occurring annually. Curren...

Full description

Bibliographic Details
Main Authors:	Greta Volpedo, Parna Bhattacharya, Sreenivas Gannavaram, Thalia Pacheco-Fernandez, Timur Oljuskin, Ranadhir Dey, Abhay R. Satoskar, Hira L. Nakhasi
Format:	Article
Language:	English
Published:	MDPI AG 2022-04-01
Series:	Pathogens
Subjects:	<i>Leishmania</i> visceral leishmaniasis vaccine live attenuated parasite vaccines pan-<i>Leishmania</i> vaccine
Online Access:	https://www.mdpi.com/2076-0817/11/4/431

Similar Items

Leishmania Major Centrin Gene-Deleted Parasites Generate Skin Resident Memory T-Cell Immune Response Analogous to Leishmanization
by: Nevien Ismail, et al.
Published: (2022-03-01)

<i>In Vitro</i> Drug Susceptibility of a <i>Leishmania (Leishmania) infantum</i> Isolate from a Visceral Leishmaniasis Pediatric Patient after Multiple Relapses
by: Bianca A. Ferreira, et al.
Published: (2023-07-01)

LBMPL Vaccine Therapy Induces Progressive Organization of the Spleen Microarchitecture, Improved Th1 Adaptative Immune Response and Control of Parasitism in <i>Leishmania infantum</i> Naturally Infected Dogs
by: Bruno Mendes Roatt, et al.
Published: (2022-08-01)

<i>Leishmania</i> Immunity: Advancing Immunotherapy and Vaccine Development
by: Nnamdi M. Ikeogu, et al.
Published: (2020-08-01)

Centrin-Deleted Leishmania donovani Parasites Help CD4+ T Cells to Acquire Th1 Phenotype and Multi-Functionality Through Downregulation of CD200–CD200R Immune Inhibitory Axis
by: Rakesh K. Singh, et al.
Published: (2018-06-01)

Biomarkers of safety and immune protection for genetically modified live attenuated Leishmania vaccines against visceral leishmaniasis-Discovery and implications
by: Sreenivas eGannavaram, et al.
Published: (2014-05-01)

Comparative Draft Genomes of <i>Leishmania orientalis</i> Isolate PCM2 (Formerly Named <i>Leishmania siamensis</i>) and <i>Leishmania martiniquensis</i> Isolate PCM3 from the Southern Province of Thailand
by: Pornchai Anuntasomboon, et al.
Published: (2022-03-01)

Revival of Leishmanization and Leishmanin
by: Thalia Pacheco-Fernandez, et al.
Published: (2021-03-01)

A Tailored Approach to Leishmaniases Vaccination: Comparative Evaluation of the Efficacy and Cross-Protection Capacity of DNA vs. Peptide-Based Vaccines in a Murine Model
by: Alicia Mas, et al.
Published: (2023-08-01)

Berberine-Loaded Liposomes for the Treatment of <i>Leishmania infantum</i>-Infected BALB/c Mice
by: Alba Calvo, et al.
Published: (2020-09-01)

Modulation of innate immune mechanisms to enhance vaccine induced immunity: Role of co-inhibitory molecules
by: Sreenivas eGannavaram, et al.
Published: (2016-05-01)

Genetic Diversity and Population Structure of <i>Leishmania infantum</i> in Morocco as Revealed by Multilocus Sequence Typing (MLST) Approach
by: Sara El Mazini, et al.
Published: (2023-05-01)

Immunization with <i>centrin</i>-Deficient <i>Leishmania braziliensis</i> Does Not Protect against Homologous Challenge
by: Francys Avendaño-Rangel, et al.
Published: (2024-03-01)

Next-Generation Leishmanization: Revisiting Molecular Targets for Selecting Genetically Engineered Live-Attenuated <i>Leishmania</i>
by: Paulo O. L. Moreira, et al.
Published: (2023-04-01)

Effects of a Serine Protease Inhibitor N-<i>p</i>-Tosyl-L-phenylalanine Chloromethyl Ketone (TPCK) on <i>Leishmania amazonensis</i> and <i>Leishmania infantum</i>
by: Patrícia de A. Machado, et al.
Published: (2022-06-01)

Insights on Host–Parasite Immunomodulation Mediated by Extracellular Vesicles of Cutaneous <i>Leishmania shawi</i> and <i>Leishmania guyanensis</i>
by: Juliana Inês Weber, et al.
Published: (2023-04-01)

Oral and Intragastric: New Routes of Infection by <i>Leishmania braziliensis</i> and <i>Leishmania infantum</i>?
by: Mayra M. Reimann, et al.
Published: (2022-06-01)

Exploring Host-Specificity: Untangling the Relationship between <i>Leishmania</i> (<i>Viannia</i>) Species and Its Endosymbiont <i>Leishmania RNA Virus</i> 1
by: Mayara Cristhine de Oliveira Santana, et al.
Published: (2023-09-01)

Cinnamides Target <i>Leishmania amazonensis</i> Arginase Selectively
by: Edson Roberto da Silva, et al.
Published: (2020-11-01)

Extracellular Vesicles Released by <i>Leishmania (Leishmania) amazonensis</i> Promastigotes with Distinct Virulence Profile Differently Modulate the Macrophage Functions
by: Rogéria Cristina Zauli, et al.
Published: (2023-12-01)

Effect of Clindamycin on Intestinal Microbiome and Miltefosine Pharmacology in Hamsters Infected with <i>Leishmania infantum</i>
by: Ana Isabel Olías-Molero, et al.
Published: (2023-02-01)

Malnutrition Aggravates Alterations Observed in the Gut Structure and Immune Response of Mice Infected with <i>Leishmania infantum</i>
by: Felipe Gaitán-Albarracín, et al.
Published: (2021-06-01)

The Maze Pathway of Coevolution: A Critical Review over the <i>Leishmania</i> and Its Endosymbiotic History
by: Lilian Motta Cantanhêde, et al.
Published: (2021-04-01)

Central and Effector Memory Human CD4<sup>+</sup> and CD8<sup>+</sup> T Cells during Cutaneous Leishmaniasis and after In Vitro Stimulation with <i>Leishmania (Viannia) braziliensis</i> Epitopes
by: Beatriz Coutinho de Oliveira, et al.
Published: (2023-01-01)

Insights into <i>Leishmania</i> Molecules and Their Potential Contribution to the Virulence of the Parasite
by: Ehab Kotb Elmahallawy, et al.
Published: (2021-02-01)

In Vitro Anti-Leishmanial Effect of Metallic Meso-Substituted Porphyrin Derivatives against <i>Leishmania braziliensis and Leishmania panamensis</i> Promastigotes Properties
by: Fabian Espitia-Almeida, et al.
Published: (2020-04-01)

Efficacy of an Immunotherapy Combining Immunogenic Chimeric Protein Plus Adjuvant and Amphotericin B against Murine Visceral Leishmaniasis
by: Danniele L. Vale, et al.
Published: (2023-06-01)

Role of Host and Parasite MIF Cytokines during <i>Leishmania</i> Infection
by: Thomas Holowka, et al.
Published: (2020-03-01)

First Evidence of Co-Circulation of Emerging <i>Leishmania martiniquensis</i>, <i>Leishmania orientalis</i>, and <i>Crithidia</i> sp. in <i>Culicoides</i> Biting Midges (Diptera: Ceratopogonidae), the Putative Vectors for Autochthonous Transmission in Southern Thailand
by: Nopporn Songumpai, et al.
Published: (2022-11-01)

Structure and Antiparasitic Activity Relationship of Alkylphosphocholine Analogues against <i>Leishmania donovani</i>
by: Humera Ahmed, et al.
Published: (2020-07-01)

Independent Circulation of <i>Leishmania major</i> and <i>Leishmania tropica</i> in Their Respective Sandfly Vectors for Transmission of Zoonotic and Chronic Cutaneous Leishmaniasis Co-Existing in a Mixed Focus of Central Tunisia
by: Mohammed Abdo Saghir Abbas, et al.
Published: (2022-07-01)

Infection of <i>Leishmania donovani</i> in <i>Phlebotomus orientalis</i> Sand Flies at Different Microhabitats of a Kala-Azar Endemic Village in Eastern Sudan
by: Altayeb Khogali, et al.
Published: (2024-02-01)

In Vitro Leishmanicidal Activity of Copaiba Oil and Kojic Acid Combination on the Protozoan <i>Leishmania (Leishmania) amazonensis</i> and Host Cell
by: Lienne Silveira de Moraes, et al.
Published: (2023-12-01)

The Preclinical Validation of 405 nm Light Parasiticidal Efficacy on <i>Leishmania donovani</i> in Ex Vivo Platelets in a Rag2<sup>−/−</sup> Mouse Model
by: Pravin R. Kaldhone, et al.
Published: (2024-01-01)

Laurequinone, a Lead Compound against <i>Leishmania</i>
by: Sara García-Davis, et al.
Published: (2023-05-01)

Leishmania vaccines entered in clinical trials: A review of literature
by: Mohammad Moafi, et al.
Published: (2019-01-01)

An RNA Interference (RNAi) Toolkit and Its Utility for Functional Genetic Analysis of <i>Leishmania</i> (<i>Viannia</i>)
by: Lon-Fye Lye, et al.
Published: (2022-12-01)

Immunogenicity of MHC Class I Peptides Derived from Leishmania Mexicana Gp63 in HLA-A2.1 Transgenic (HHDII) and BALB/C Mouse Models
by: H Rezvan, et al.
Published: (2012-12-01)

Immunoinformatics Studies and Design of a Potential Multi-Epitope Peptide Vaccine to Combat the Fatal Visceral Leishmaniasis
by: Olugbenga Samson Onile, et al.
Published: (2022-09-01)

Transcriptional Shift and Metabolic Adaptations during <i>Leishmania</i> Quiescence Using Stationary Phase and Drug Pressure as Models
by: Marlene Jara, et al.
Published: (2022-01-01)